2021 AGA Postgraduate Course

May 1, 2021 ‐ May 1, 2021


Presentations: 1


Sessions

Test SessionTest Session

Preview Available

Test Session

Mar 2, 2021 11:00am ‐ Mar 2, 2021 11:00am

Speaker(s):

President's Welcome & Course Overview

May 1, 2021 9:00am ‐ May 1, 2021 9:10am

Identification: 1

Speaker(s):

Course OverviewCourse Overview

Preview Available

Course Overview

May 1, 2021 9:05am ‐ May 1, 2021 9:10am

Identification: 3

Speaker(s):

Fundoplication vs. Magnetic Sphincter Augmentation vs. TIF: If and when should I use them?

May 1, 2021 9:10am ‐ May 1, 2021 9:30am

Identification: 7.1

Presentation style: Debate

Learning Objectives:
  • Upon completion of this activity, participants will be able to describe different strategies for the treatment of gastroesophageal reflux, whilst concurrently minimising post-procedure side effects.
  • Upon completion of this activity, participants will be able to assess and compare alternative procedures for the treatment of gastroesophageal reflux.
  • Upon completion of this activity, participants will be able to evaluate the advantages and disadvantages of different procedures for the treatment of gastroesophageal reflux.
  • To define the heterogeneity of GERD patients to prove that one size does not fit all.
Debater(s):

Initiation of Colon Cancer Screening: 45 or 50 years old

May 1, 2021 9:10am ‐ May 1, 2021 9:30am

Identification: 9.1

Presentation Style: Debate

Learning Objectives:
  • Describe the epidemiologic trends of EOCRC in the US
  • List the clinical and molecular features of EOCRC
  • To understand temporal trends in the incidence of colorectal cancer (CRC) in the US
  • To learn about the results of modeling the impacts of starting screening at age 45 years
  • To appreciate the need for a stronger focus on the under/never screened age 50-75 years
Speaker(s):

Track A: EsophagusTrack A: Esophagus

Preview Available

Track A: Esophagus

May 1, 2021 9:10am ‐ May 1, 2021 10:45am

Identification: 7

Moderator(s):
  • Dr. Gary W. Falk, MD, MS, AGAF, Professor of Medicine/Director, Esophageal Program, University of Pennsylvania Perelman School of Medicine

Track B: ColonTrack B: Colon

Preview Available

Track B: Colon

May 1, 2021 9:10am ‐ May 1, 2021 10:45am

Identification: 9

Moderator(s):

Monitoring and treating a lifetime of eosinophilic esophagitis

May 1, 2021 9:30am ‐ May 1, 2021 9:50am

Identification: 7.2

Presentation style: Interview

Learning Objectives:
  • Understand the diagnostic criteria for EoE
  • Describe the rationale for maintenance treatment for EoE
  • Recognize the need for ongoing monitoring of EoE treatment response
Interviewee(s):
  • Dr. Evan S. Dellon, MD, MPH, AGAF, Professor of Medicine and Epidemiology, University of North Carolina School of Medicine
Interviewer(s):

The changing landscape of fecal microbial transplantation (FMT)

May 1, 2021 9:30am ‐ May 1, 2021 9:50am

Identification: 9.2

Presentation style: Interview

Learning Objectives:
  • To gain an understanding of the evolution of FMT over time.
  • To describe the FDA regulations surrounding FMT.
  • To develop an appreciation for how COVID-19 has affected use of FMT in clinical practice.
  • To recognize the potential indications for FMT and understand the efficacy of FMT in the treatment of C. difficile infection (CDI), IBD and IBS
Interviewee(s):
  • Olga C. Aroniadis, MD, MS, Associate Professor of Clinical Medicine, Stony Brook University Medical Center
Interviewer(s):
  • Dr. Ari M. Grinspan, MD, Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai

Screening and surveillance of Barrett’s Esophagus: Are the guidelines still helpful?

May 1, 2021 9:50am ‐ May 1, 2021 10:05am

Identification: 7.3

Presentation style: Pitfall

Learning Objectives:
  • To discuss the limitations of current screening and surveillance strategies in patients with Barrett’s esophagus
  • To highlight the advances in non-endoscopic approaches to screening for Barrett’s esophagus and esophageal adenocarcinoma
  • To provide best practice advice to optimize detection of Barrett’s esophagus related neoplasia
Speaker(s):
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content